EADV 2026 data highlight dupilumab’s effects on growth, quality of life, disease control, and itch across multiple dermatologic diseases.
|Articles|July 1, 2006
Wrinkles may warn of COPD
London - Smokers' heavily wrinkled faces could be an early warning signal of a serious lung disease, British researchers say.
Advertisement
London - Smokers' heavily wrinkled faces could be an early warning signal of a serious lung disease, British researchers say.
Investigators at Royal Devon & Exeter NHS Foundation say smokers with pronounced wrinkles are five times more likely than those without marked facial lines to suffer from chronic obstructive pulmonary disease (COPD), Reuters reports.
Researchers studied 149 former and current middle-aged smokers and compared how much they smoked during their lifetime and their sun exposure.
Advertisement
Related to this article
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.
The designation marks the first FDA Fast Track status granted to a therapy for peeling skin syndrome, which currently has no approved treatment.
Advertisement
Advertisement
Trending on Dermatology Times
1
EADV 2026 Day 2: Long-Term AD Data, GLP-1 Nail Findings, and Emerging Treatments Take Center Stage
2
EADV 2026 Day 1: Late-Breaking Data, Emerging Therapies, and New Directions in Dermatology
3
Tilrekimig Phase 2 Data Show EASI 75 Gains in Atopic Dermatitis
4
NEA Report Highlights Atopic Dermatitis Care Access Gaps by State
5